HELE · sample dossier
Helen Of Troy Ltd
52/100
OutdatedGenerated Oct 3, 2026 · 10:00 AM UTC · 1 hour ago
This copy is frozen (Oct 3). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about a minute.
Run a fresh dossierHELE
EquityHelen Of Troy LtdXNAS
Decision context
HOLD
Analysis horizon · 80% convictionA mixed picture — no strong reason to buy or sell right now.
The stock trades 70.2% below our estimated value range midpoint.
Current price
$26.74
Estimated value range
$59.15 – $129.00
Gap (vs midpoint)
+70.2%
The stock trades at a discount, but execution uncertainties suggest waiting for a clearer catalyst.
Market context
Price
Price when available
Pick how far back the chart looks
1 month
-6.5%
3 months
-2.9%
6 months
+83.2%
1 year
+3.1%
Executive summary & thesis
Helen Of Troy Ltd is a consumer products company with a market capitalization of $622.83M and share price of $26.74, trading at an EV/EBITDA of 6.21 and Price/Book of 0.74.
- Helen Of Troy generates strong cash flow of $3.39 FCF/share while trading at an EV/EBITDA multiple of 6.21.
- Revenue expanded 8.2% YoY while gross margin remained resilient at 45.4%.
- Valuation trades below book equity with a Price/Book multiple of 0.74.
- GAAP profitability is deeply compromised by a net margin of -22.7% and negative P/E of -1.50.
- Balance sheet leverage of 0.91 Debt/Equity confines the Altman Z-score to 2.03 in grey territory.
- Operational discipline is low with a Piotroski F-score of 3/9, while CEO Scott Uzzell sold $137,032 on 2026-09-02.
Things to keep in mind
- 1P/E -1.5xView source
- 2Net margin -22.7%View source
- 3GAAP profitability is deeply compromised by a net margin of -22.7% and negative P/E of -1.50.View source
What to watch next
Factor profile
Balanced operator
| Factor | Score |
|---|---|
| Quality | 48 out of 100 (Neutral). Business health — profits, returns, and consistency. Higher means a more durable company. |
| Growth | 36 out of 100 (Weak). How fast sales and earnings are rising. Higher means the business is expanding faster. |
| Value | 68 out of 100 (Neutral). How cheap the stock looks for what you get. Higher means a more attractive price. |
| Safety | 47 out of 100 (Neutral). Balance-sheet cushion and fewer red flags. Higher means less risk of a nasty surprise. |
| Momentum | 64 out of 100 (Neutral). Recent share-price trend. Higher means buyers have been in control lately. |
Another way to look at it
A calmer look at both sides of the HELE story
The consensus verdict of Hold based on an EV/EBITDA of 6.2 and Price/Book of 0.74 dangerously understates Helen Of Troy's solvency trajectory.
Trailing free cash flow of $3.39 per share is being mistaken for operational health, masking what is typical working-capital unwind during a top-line collapse from $512.83M in November 2025 to $402.12M in May 2026. With GAAP net margin sitting at -22.7% and a Piotroski F-score of 3/9, negative operating leverage is actively destroying equity value faster than book multiples can adjust. Furthermore, consensus assumes a 0.91 Debt/Equity ratio and a grey-zone Altman Z-score of 2.03 are manageable, ignoring that debt service becomes punitive after a 21.6% sequential revenue contraction. Dismissing CEO Scott Uzzell's $137,032 stock sale on 2026-09-02 while celebrating token 860-share director buys is classic value-trap rationalization. The stock is not stabilizing; its deteriorating core fundamentals point to an asymmetric downside that invalidates the neutral consensus.
FCF per share of $3.39 is treated as sustainable run-rate yield (13.6%) rather than temporary cash harvest driven by inventory liquidation amidst sequential sales declines from $512.83M to $402.12M.
A Price/Book multiple of 0.74 is framed as downside support, ignoring that a trailing net margin of -22.7% and P/E of -1.50 will directly erode the remaining equity base.
Operational data from the May 2026 quarter is now stale (>90 days old as of 2026-10-03), obscuring whether debt covenants are tightening under the 0.91 Debt/Equity load.
Citing 8.2% YoY revenue growth as a strength while ignoring the two consecutive sequential contractions from $512.83M in November 2025 to $470.02M in February 2026 and $402.12M in May 2026.
Relying on a 45.4% gross margin as evidence of pricing power despite operational decay reflected in a Piotroski F-score of 3/9.
Treating the EV/EBITDA multiple of 6.2 as a bargain multiple when the Altman Z-score of 2.03 sits in the grey zone of financial distress.
Net margin improves above -22.7% toward positive territory.
Revenue Growth YoY decelerates below 8.2%.
Cash after investing
See whether HELE still makes cash after it spends to grow.
- Net margin improves above -22.7% toward positive territory.
- Revenue Growth YoY decelerates below 8.2%.
- Net margin expands above -22.7% for two consecutive quarters
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full HELE dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.